FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |   Search Term  Advanced Search

Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe

Previous Volume 330:290-291 January 27, 1994 Number 4 Next

	Since this article has no abstract, we have provided an extract of the first 100 words of the full text and any section headings.

	Full Text Purchase this article Add to Personal Archive Add to Citation Manager Notify a Friend E-mail When Cited Related Article Related Article by The European Myocardial Infarction Project Group

To the Editor: The study of prehospital thrombolytic therapy by the European Myocardial Infarction Project (EMIP) Group, published in the August 5 issue of the Journal,¹ showed a nonsignificant reduction in mortality among patients treated before admission (the prehospital group) as compared with those who underwent thrombolysis in the hospital. The number of patients recruited was limited, but this may not be the only reason that the difference in mortality was not statistically significant.

The relation between the benefit derived from thrombolytic therapy and the time of onset of myocardial infarction is not linear. It has been shown² that thrombolytic . . . [Full Text of this Article]

References

HOME  |  SUBSCRIBE  |  SEARCH  |  CURRENT ISSUE  |  PAST ISSUES  |  COLLECTIONS  |  PRIVACY  |  TERMS OF USE  |  HELP  |  beta.nejm.org Comments and questions? Please contact us. The New England Journal of Medicine is owned, published, and copyrighted © 2009 Massachusetts Medical Society. All rights reserved.